| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | NOVAVAX, INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$120,000 | |
| 2026 | NOVAVAX, INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$130,000 | |
| 2026 | NOVAVAX, INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$140,000 | |
| 2025 | NOVAVAX, INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$110,000 | |
| 2025 | NOVAVAX, INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$230,000 | |
| 2025 | NOVAVAX, INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$190,000 | |
| 2025 | NOVAVAX, INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$170,000 | |
| 2024 | NOVAVAX, INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$100,000 | |
| 2024 | NOVAVAX, INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$90,000 | |
| 2024 | NOVAVAX, INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$90,000 |
| Firm | Filings | Expenses |
|---|---|---|
| NOVAVAX, INC | 43 | $3,450,000 |
| Issue | Activities |
|---|---|
| Health Issues | 37 |
| Taxation/Internal Revenue Code | 15 |
| Budget/Appropriations | 10 |
| Medicare/Medicaid | 3 |